Skin Lymphoma

Lorenzo Cerroni, Professor of Dermatology and Venereology, Medical University of Graz, Graz, Austria. Professor Cerroni is the Director of both the Cutaneous Lymphoma Unit and the Dermatopathology Research Center at the University of Graz. He is a former president of the International Society of Dermatopathology (2001-2004).

List of teaching cases, vii Preface, ix Acknowledgments, xi 1 Introduction, 1 Section 1: Cutaneous NK/T-cell lymphomas 2 Mycosis fungoides, 11 3 Sezary syndrome, 74 4 Primary cutaneous CD30+ lymphoproliferative disorders, 85 Lymphomatoid Papulosis, 86 Cutaneous Anaplastic Large Cell Lymphoma, 99 Borderline Cases, 109 5 Subcutaneous panniculitis-like T-cell lymphoma, 120 6 Aggressive cutaneous cytotoxic lymphomas, 133 Primary Cutaneous Aggressive Epidermotropic CD8+ Cytotoxic T-cell Lymphoma, 134 Primary Cutaneous / T-cell Lymphoma, 137 Cutaneous Extranodal NK/T-cell Lymphoma, Nasal Type, 143 7 Cutaneous peripheral T-cell lymphoma, not otherwise specified (NOS), 155 8 Cutaneous CD4+ small medium T-cell lymphoma, 163 Indolent CD8+ Lymphoid Proliferation of the Ear (Face), 166 Primary Cutaneous T-follicular helper (TFH)-cell Lymphoma, 167 9 Cutaneous adult T-cell leukemia/lymphoma, 172 10 Other cutaneous NK/T-cell lymphomas, 176 Angioimmunoblastic T-cell Lymphoma, 176 Hydroa Vacciniforme-Like Lymphoma, 179 Section 2: Cutaneous B-cell lymphomas 11 Cutaneous follicle center lymphoma, 185 12 Cutaneous marginal zone lymphoma (cutaneous MALT-lymphoma) and variants, 201 Cutaneous Marginal Zone Lymphoma, Conventional Variant, 202 Cutaneous Marginal Zone Lymphoma, Lymphoplasmacytic Variant, 208 Cutaneous Marginal Zone Lymphoma, Plasmacytic Variant, 212 Cutaneous Marginal Zone Lymphoma, Blastoid Variant, 213 13 Cutaneous diff use large B-cell lymphoma, leg type, 220 14 Intravascular large cell lymphomas, 232 Intravascular Large B-cell Lymphoma, 232 Intravascular Large NK/T-cell Lymphoma, 237 Intralymphatic CD30+ Large T-cell Lymphoma, 239 15 Other cutaneous B-cell lymphomas, 245 Cutaneous EBV+ Diff use Large B-cell Lymphoma of the Elderly, 245 Specific Cutaneous Manifestations in Mantle Cell Lymphoma, 247 Specific Cutaneous Manifestations in Extracavitary Primary Effusion Lymphoma, 248 Specific Cutaneous Manifestations in Multiple Myeloma, 250 Specific Cutaneous Manifestations in Burkitt Lymphoma, 252 Cutaneous Lymphomatoid Granulomatosis, 253 Cutaneous Plasmablastic Lymphoma, 256 Cutaneous T-cell/Histiocyte-rich B-cell Lymphoma, 258 Section 3: Cutaneous lymphomas in immunosuppressed individuals 16 Cutaneous post-transplant lymphoproliferative disorders, 265 17 Cutaneous lymphomas in HIV-infected individuals, 275 18 Cutaneous lymphoproliferative disorders in other iatrogenic and non-iatrogenic immune defi ciencies, 281 Section 4: Specific cutaneous manifestations of leukemias and of precursor hematologic neoplasms 19 Cutaneous manifestations of B-cell chronic lymphocytic leukemia, 287 20 Cutaneous manifestations of myelogenous leukemia, 296 21 Blastic plasmacytoid dendritic cell neoplasm, 306 22 Cutaneous manifestations of other leukemias, 317 T-cell Prolymphocytic Leukemia, 317 Aggressive Natural Killer Cell Leukemia, 318 Specifi c Skin Manifestations of other Types of Leukemia, 319 23 Cutaneous lymphoblastic lymphomas, 320 Cutaneous B-lymphoblastic Lymphoma, 320 Cutaneous T-lymphoblastic Lymphoma, 323 Section 5: Cutaneous manifestations of Hodgkin lymphoma 24 Cutaneous manifestations of Hodgkin lymphoma, 331 Section 6: Cutaneous lymphomas in children and adolescents 25 Cutaneous lymphomas in children and adolescents, 341 Section 7: Pseudolymphomas of the skin 26 Pseudolymphomas of the skin, 351 Actinic reticuloid, 353 Lymphomatoid contact dermatitis, 354 Solitary idiopathic B/T-cell pseudolymphoma, 355 Lichenoid (lymphomatoid) keratosis, 357 Lichen aureus/lichenoid pigmented purpuric dermatitis, 357 Lichen sclerosus, 359 Vitiligo, 360 Annular lichenoid dermatitis of youth, 361 Pseudolymphomatous acrodermatitis chronica atrophicans, 361 Pseudolymphomatous atopic dermatitis, 362 Non-neoplastic erythroderma in adult patients, 363 Pseudolymphomatous cutaneous infi ltrates in human immunodeficiency virus (HIV)-infected patients and in other immune deficiencies, 367 CD30+ T-cell pseudolymphomas, 367 Persistent nodular arthropod bite reactions and nodular scabies, 369 Pseudolymphomas in herpes simplex and herpes zoster infections, 371 Epstein Barr virus (EBV)-associated mucocutaneous ulcers, 372 Hydroa vacciniforme, 373 Pityriasis lichenoides, 374 Pseudolymphomas associated with lupus erythematosus, 376 Lymphomatoid drug reactions, 379 Lymphocytoma cutis, 380 Pseudolymphomas at sites of vaccination, 384 Pseudolymphomas in tattoos, 385 Localized scleroderma/morphea, 386 Cutaneous IgG4-related disease, 386 Pseudolymphomas in syphilis, 386 Cutaneous plasma cell granuloma, 388 Cutaneous and systemic plasmacytosis, 389 Cutaneous manifestations of Castleman disease, 392 Pre-tibial lymphoplasmacytic plaque in children, 393 Cutaneous extramedullary hematopoiesis, 394 Histiocytoid Sweet syndrome, 395 Intralymphatic histiocytosis, 396 Benign intralymphatic proliferation of T-cell lymphoid blasts, 397 Other accidental pseudolymphomas, 398 Malignant pseudolymphomas, 399 Section 8: The cutaneous atypical lymphoid proliferation 27 The cutaneous atypical lymphoid proliferation , 413 Index, 415